Please login to the form below

Not currently logged in
Email:
Password:

chronic lung disease

This page shows the latest chronic lung disease news and features for those working in and with pharma, biotech and healthcare.

FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19

FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19

All participants in this trial had at least one risk factor for developing severe COVID-19, including chronic lung disease, obesity, cardiovascular disease or were at least 50 years of age. ... high-risk of severe disease or hospitalisation.

Latest news

More from news
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...